Public-registry site landscape for NCT04434482, a Advanced Solid Tumours study sponsored by Impact Therapeutics, Inc.. All data below is from public sources; Eichor is not affiliated with the sponsor.
| Trial | NCT04434482 (registry record) |
| Sponsor | Impact Therapeutics, Inc. |
| Condition(s) | Advanced Solid Tumours; Small Cell Lung Cancer |
| Phase | PHASE1 / PHASE2 |
| Listed sites | 21 |
| Site countries | United States, Australia, China, South Korea, Taiwan |
Eichor generates a preliminary site-risk snapshot for NCT04434482 — how the roster screens on competing-trial load, enrollment track record, and PI–indication fit — free, usually same day. Request it here →